Omnazide TZ 250mg/31.25mg Injection
Marketer
Innovative Pharmaceuticals
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Omnazide TZ 250mg/31.25mg Injection
Tazocin 250mg/31.25mg injection is a dual-action antibiotic prescribed for diverse bacterial infections. Its mechanism combats microbial proliferation, halting infection progression. Administration must be under a doctor's guidance; adhere strictly to the prescribed schedule. Complete the full course, even with symptom improvement, as premature cessation may reduce efficacy. Potential side effects include nausea, vomiting, diarrhea, and dyspepsia; consult your physician if these worsen. Seek immediate medical attention for allergic reactions (rash, itching, swelling, respiratory distress). Inform your doctor about all other medications, and pregnant or breastfeeding individuals should seek medical advice prior to use. Alcohol should be avoided due to potential increased drowsiness. While it typically doesn't affect driving, refrain from driving if drowsiness or dizziness occurs. Adequate rest, a balanced diet, and hydration are crucial for optimal recovery. Your doctor might order blood tests to monitor treatment effectiveness.
Uses of Omnazide TZ 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Omnazide TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Omnazide TZ 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Omnazide TZ 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Omnazide TZ 250mg/31.25mg Injection works:
Omnazide TZ Injection (250mg Ceftazidime/31.25mg Tazobactam) unites a cephalosporin antibiotic, Ceftazidime, with the beta-lactamase inhibitor, Tazobactam. Ceftazidime disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counters bacterial resistance mechanisms, optimizing Ceftazidime's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concomitant use of Omnazide TZ 250mg/31.25mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Pregnancy use of Omnazide TZ 250mg/31.25mg Injection is typically deemed safe. Preclinical trials in animals revealed minimal or absent harm to the fetus; nonetheless, data from human trials are scarce.
Breast feedingSAFE IF PRESCRIBED
The injectable medication Omnazide TZ 250mg/31.25mg is considered safe for use while breastfeeding. Research in humans indicates negligible transfer of the drug into breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Administering Omnazide TZ 250mg/31.25mg Injection might induce drowsiness, visual disturbances, or dizziness. Refrain from operating vehicles should these effects manifest.
KidneyCAUTION
The injectable medication Omnazide TZ 250mg/31.25mg requires careful administration for individuals with impaired kidney function. Dosage modifications for Omnazide TZ 250mg/31.25mg Injection may be necessary. Physician consultation is recommended.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Omnazide TZ 250mg/31.25mg Injection. Dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Omnazide TZ 250mg/31.25mg Injection :
Should you forget a scheduled dose of Omnazide TZ 250mg/31.25mg Injection, seek medical advice.
Facts to Know About Omnazide TZ 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |
3,018 People bought this recently